MedPath

Internet - Based Shamiri Single Session Interventio

Not Applicable
Conditions
Mental and Behavioural Disorders
Registration Number
PACTR201906810558181
Lead Sponsor
Tom Osborn
Brief Summary

Compared to the control, Shamiri-Digital produced greater reduction in adolescent depression symptoms in both the full sample (p = 0.028, d = 0.50) and a sub-sample of youths with moderate-to-severe depression symptoms (p = 0.010, d = 0.83) from baseline to two-week follow-up. The effects exceed the mean effects reported in meta-analyses of full-length, face-to-face psychotherapy for youth depression. There were no significant effects on anxiety symptoms, well-being, or happiness.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
130
Inclusion Criteria

Participants must be aged between 13 and 18.

Exclusion Criteria

There is no exclusion criteria for any participant who meets the inclusion criteria.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in self-reported depression symptoms as measured by the Patient Health Questionnaire - 8 ;Changes in self-reported anxiety symptoms, measured by the Generalized Anxiety Disorder Screener - 7;Changes in self-reported mental well-being as indicated by the The Short Warwick–Edinburgh<br>Mental Well-being Scale (SWEMWBS)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath